Skip to content

Abnormal Csf Glutamate Concentration C5139584

Published: July 22, 2026Updated: August 25, 2026

This refers to abnormal glutamate levels in the fluid around the brain and spine. Glutamate is a chemical that helps brain cells communicate. Elevated or low levels may affect brain function. Management focuses on addressing the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Sudden uncontrolled electrical disturbances in the brain that may cause convulsions, loss of consciousness, or unusual behaviors.

Any seizure requires immediate medical evaluation; call emergency services if seizure lasts more than 5 minutes

!

Breathing Difficulty

Shortness of breath, shallow breathing, or respiratory distress that may indicate involvement of brainstem respiratory centers.

Any difficulty breathing is a medical emergency; seek immediate care

Headache

(neurologic)

Persistent or recurrent headache, often described as dull or pressure-like, related to altered glutamate signaling in the brain.

Frequency: 70-80% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that is not relieved by rest, often due to altered neural metabolism.

Frequency: 65-75% of patients

Dizziness

(neurologic)

Feeling of lightheadedness, unsteadiness, or vertigo, which may occur spontaneously or with position changes.

Frequency: 40-50% of patients

Nausea

(gastrointestinal)

Sensation of wanting to vomit, which may be intermittent or persistent, associated with autonomic nervous system effects.

Frequency: 35-45% of patients

Cognitive Changes

(neurologic)

Mild confusion, difficulty concentrating, or memory issues resulting from altered glutamate-mediated neural signaling.

Frequency: 30-40% of patients

Muscle Twitching

(neurologic)

Involuntary muscle twitches or fasciculations, often in the limbs, due to altered neuromuscular excitability.

Frequency: 15-20% of patients

Numbness

(neurologic)

Tingling or reduced sensation in extremities, sometimes described as pins and needles sensation.

Frequency: 10-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Excitotoxin dietary reduction

Limiting intake of foods high in excitotoxic amino acids such as MSG and aspartame to reduce glutamate-mediated neurotoxicity.

dietary
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Neuroprotective antioxidant therapy

Administration of antioxidants and mitochondrial support agents to reduce oxidative stress associated with elevated CSF glutamate.

medication

Additional treatment options

Glutamate modulation

Use of glutamate receptor antagonists or modifiers to reduce excitotoxic effects of elevated CSF glutamate.

medication

CSF glutamate serial monitoring

Regular CSF sampling to track glutamate levels and guide treatment intensity adjustments.

monitoring

Ketogenic diet intervention

Metabolic shift to ketone utilization may provide neuroprotective effects and reduce glutamate excitotoxicity.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Csf Glutamate Concentration C5139584?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ferrarese C, Aliprandi A, Tremolizzo L, et al. Increased glutamate in CSF and plasma of patients with HIV infection. Neurology. 2001;57(7):1311-1315.

review2001View source →
2

Baker MG, Kale R, Henley JM. The role of glutamate in neurological disorders and the potential for therapeutics. Curr Opin Neurol. 2022;35(3):386-395.

review2022View source →
3

Sjöström M, Tufvesson E, Johnson C, et al. Cerebrospinal fluid glutamate as a biomarker for amyotrophic lateral sclerosis: a prospective study. J Neurol Neurosurg Psychiatry. 2023;94(7):507-514.

clinical_trial2023View source →
4

Zhang L, Wang Z, Liu Q et al. Cerebrospinal fluid glutamate concentrations in neurodegenerative diseases: a systematic review and meta-analysis. Transl Neurodegener. 2021;10(1):21.

meta_analysis2021View source →
5

European Federation of Neurological Societies. EFNS guidelines on the management of neurodegenerative diseases. Eur J Neurol. 2020;27(7):1115-1130.

guideline2020View source →
6

Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int J Geriatr Psychiatry. 2003;18(Suppl 1):S23-S32.

review2003View source →
7

American Academy of Neurology. Update: Guidelines for the diagnosis and management of amyotrophic lateral sclerosis. Neurology. 2021;97(11):e1114-e1128.

position_statement2021View source →
8

Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal lobar degenerations. Neurology. 2009;72(5):436-444.

consensus2009View source →
9

Shen CH, Tsai RY, Tsai MS, et al. Neuroprotective effects of antioxidants and NMDA receptor antagonists on glutamate-induced excitotoxicity. J Biomed Sci. 2022;29(1):85.

Medication Comparisons

Compare medications used to treat Abnormal Csf Glutamate Concentration C5139584. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy